Second cancer risk in childhood cancer survivors treated with intensity-modulated radiation therapy: An updated analysis of more than 10 years of follow-up.
Kathryn R TringaleDana L CaseyGregory NiyazovJessica A LaveryChaya MoskowitzDanielle Novetsky FriedmanSuzanne L WoldenPublished in: Pediatric blood & cancer (2022)
With median follow-up of >10 years, many solid SMNs after IMRT in childhood cancer survivors develop in the high-dose region. These data serve as a foundation for comparison with other modalities of radiation treatment (e.g., proton therapy).